Drug Approvals
🇺🇸 FDA Page 31FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 361–372 of 665 articles
Long-Term Medical Consequences of Retained Bullet Fragments
Are AI Co-Scientist Tools Useful for Scientists?
Kennedy Appoints Interim Surgeon General: Implications for Pharma
Pfizer's Next-Gen Pneumonia Shot Outperforms Prevnar 20
GHO Capital and CBC Group Merge: A New Era in Healthcare Investment
Parabilis Pursues IPO After $800M Funding for Undruggable Targets
Tarsus Partners with John Cena for Demodex Blepharitis Campaign
Bristol Myers Squibb Leverages AI for Enhanced R&D Efficiency
How GLP-1s are Transforming Pharma's Consumer Relationships
Acceleron and Westlake Launch New IPF Biotech Venture
BioMarin's SWOT Analysis: Competitive Headwinds in Rare Disease Biotech
Paragon's Reverse Merger: Implications for Migraine Drug Development